NCT00413686View on ClinicalTrials.gov

Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Solid Tumors
Interventions
DRUG

AZD7762

intravenous infusion

DRUG

Gemcitabine

weekly intravenous infusion

Trial Locations (2)

Unknown

Research Site, Baltimore

Research Site, Detroit

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY